ARL Bio Pharma
Oklahoma City, OK
High Approval Rate
5+ Years Sponsoring
ARL Bio Pharma has sponsored 20 H1B visas since FY2010. The median H1B salary is $61,350.
H1B Visa Sponsorship Data • Updated with FY2025 data
Key Statistics
H1B Salary Analysis at ARL Bio Pharma
Salary Range (FY2025)
Range shows where 80% of salaries fall. The marker indicates the median.
Based on 10 H1B filings.
Salary Frequency
Hover over bars to see exact counts. Salary ranges in $25K increments.
Historical H1B Trends
Filings Over Time
Median Salary Trend
Approval Rate History
Certified: 10
Denied: 0
Where & What ARL Bio Pharma Hires For
ARL Bio Pharma sponsors H1B workers at locations including Oklahoma City, OK, Oklahoma, OK for roles such as Chemists, Project Management Specialists.
Top H1B Work Locations (FY2025)
Top H1B Job Categories (FY2025)
Recent H1B Filings
View all 20 filings →Data Review Chemist III-GMP
Oklahoma City, OK • FY2025
$83,200
Certified
R&D Project Coordinator
Oklahoma City, OK • FY2025
$57,762
Certified
Senior Data Review Scientist
Oklahoma, OK • FY2025
$79,040
Certified
Project Manager II
Oklahoma City, OK • FY2025
$113,300
Certified
Senior Protein Characterization Scientist
Oklahoma City, OK • FY2025
$110,000
Certified
Year-by-Year Breakdown
Related H1B Sponsors
Other Life & Physical Sciences Companies
H1B Sponsors in Oklahoma
Frequently Asked Questions
- Does ARL Bio Pharma sponsor H1B visas?
- Yes, ARL Bio Pharma sponsors H1B visas. They have filed 20 H1B petitions since FY2010. In FY2025, they filed 10 H1B applications.
- What is the H1B salary at ARL Bio Pharma?
- The median H1B salary at ARL Bio Pharma is $61,350 as of FY2025. Salaries range from $54,787 (10th percentile) to $110,330 (90th percentile).
- What is ARL Bio Pharma's H1B approval rate?
- ARL Bio Pharma has a 100.0% H1B approval rate in FY2025, based on 10 filed petitions.
- How many H1B visas does ARL Bio Pharma sponsor per year?
- ARL Bio Pharma sponsors an average of 4 H1B visas per year. They have been sponsoring H1B workers for 5 years (FY2010-FY2025).